Medibank Private Limited
MDBPF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -3.17 | 0.46 | -1.70 |
| FCF Yield | 3.19% | 9.86% | 2.55% | 11.07% |
| EV / EBITDA | 13.09 | 9.61 | 9.57 | 11.60 |
| Quality | ||||
| ROIC | 10.84% | 5.64% | 16.42% | 13.21% |
| Gross Margin | 22.13% | 21.56% | 21.86% | 19.92% |
| Cash Conversion Ratio | 0.76 | 1.76 | 0.51 | 2.44 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.45% | 4.17% | 2.27% | 1.52% |
| Free Cash Flow Growth | -54.41% | 274.90% | -76.68% | 100.30% |
| Safety | ||||
| Net Debt / EBITDA | -0.78 | -0.59 | -0.43 | -0.77 |
| Interest Coverage | 66.25 | 131.80 | 403.94 | 233.33 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -8.76 | -6.91 |
| Cash Conversion Cycle | 0.00 | -7.71 | -43.01 | -56.74 |